MedTrace Logo

Tributyrin: Time Course & Efficacy to Improve Health & Performance

NCT06501898 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2025-04-13

No results posted yet for this study

Summary

The purpose of this study is to determine if tributyrin supplementation improves metabolite concentrations, overall health biomarkers, and performance in sedentary men and women. The study would further understand the potential usage of tributyrin as a health and performance increasing supplement through improving gut and immune health, sleep, and performance as well as reduce inflammation. Participants will supplement for tributyrin for 4 weeks and complete fecal metabolite measures, cardiovascular evaluation, sleep assessment, and exercise testing as well as provide blood samples.

Conditions

  • Metabolite Concentration
  • Gut Permeability
  • Inflammation
  • Sleep
  • Performance

Interventions

DIETARY_SUPPLEMENT

CoreBiome

300 mg, once daily of tributyrin for 4 weeks

DIETARY_SUPPLEMENT

Placebo

300 mg, once daily of placebo for 4 weeks

Sponsors & Collaborators

  • Compound Solutions Inc.

    collaborator INDUSTRY

  • Florida State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-19
Primary Completion
2025-03-01
Completion
2025-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06501898 on ClinicalTrials.gov